No. 22A272
Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd., et al.
Tags: None
Latest Conference:
N/A
Question presented not available.
Docket Entries
2022-10-13
Application (22A272) referred to the Court.
2022-10-13
Application (22A272) for stay of the mandate presented to The Chief Justice and by him referred to the Court is denied. The order heretofore entered by The Chief Justice is vacated.
2022-10-11
Supplemental letter from applicant filed.
2022-10-11
Supplemental letter from respondents filed.
2022-10-07
Reply of applicant Novartis Pharmaceuticals Corporation filed.
2022-10-05
Response to application from respondent HEC Pharm Co., Ltd., et al. filed.
2022-09-29
Upon consideration of the application of counsel for the applicant, it is ordered that the mandate of the United States Court of Appeals for the Federal Circuit, case No. 2021-1070, is hereby stayed pending further order of The Chief Justice or of the Court. It is further ordered that a response to the application be filed on or before Wednesday, October 5, 2022, by noon (EDT).
2022-09-28
Application (22A272) for a stay, submitted to The Chief Justice.
Attorneys
HEC Pharm Co., Ltd., et al.
Peter K. Stris — Stris and Maher LLP, Respondent
Novartis Pharmaceuticals Corporation
William McGinley Jay — Goodwin Procter, LLP, Petitioner